cagrilintide and semaglutide New in the August 14, 2025, issue of NEJM: ⁣ ⁣ Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial)⁣ ⁣ Cagrilintide– for Overweight Diabetes (REDEFINE 2 phase 3a trial)⁣ ⁣ We are all anxiously awaiting

The results came even faster than what I read online about people getting GLP-1 injections at medical facilities

Unlike manufactured branded medications, compounded semaglutide formulations require a valid prescription from a licensed healthcare provider and should only be dispensed by accredited pharmacies with quality assurance protocols in place

pmid:36771262 28

however, when compared with semaglutide 1.0 mg in type 2 diabetes, in doses of 5 mg, 10 mg and 15 mg, tirzepatide resulted in significantly greater body-weight reductions [5]

Chronic low-grade inflammation (inflammaging) is increasingly recognized as a driver of age-related disease, and BPC-157s ability to modulate inflammatory pathways may have broader implications for healthy aging